-
Mashup Score: 0The Disconnect between R&D Costs and High Drug Prices - MedCity News - 5 month(s) ago
Multiple studies have shown no correlation between R&D costs and the launch price of new drugs though that is an argument often used by drugmakers to prevent a cap on pricing. Still, one way to keep costs low, is for organizations to leverage health technology like AI and improve formulary compliance.
Source: medcitynews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0How Might IRA’s Drug-Pricing Provisions Affect Stakeholders - 5 month(s) ago
As drugs become subject to price negotiation, how will pharma companies and other stakeholders be affected?
Source: www2.deloitte.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0UnitedHealth wants to make weight loss drugs cheaper - 6 month(s) ago
UnitedHealth Group is pushing for lower prices for GLP-1 drugs like Ozempic and Wegovy, which are used to treat Type 2 diabetes and for weight loss.
Source: www.beckerspayer.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Select Health, Mark Cuban team to lower prescription drug costs - 7 month(s) ago
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.
Source: www.healthcarefinancenews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
September 14, 2023 | Join this Dbriefs to identify how drug pricing changes may affect their organization and expected changes over the next 6-12 months.
Source: www2.deloitte.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Medicare's priciest drugs may get cheaper as feds start negotiations. Big Pharma objects. - 8 month(s) ago
For the first time, the federal government is allowed to negotiate drug prices for older Americans. Medicare will name the first 10 drugs by Friday.
Source: www.usatoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
It’s not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments as demand for these therapies grows | It’s not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments like Ozempic and Wegovy.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0CVS Caremark partners with GoodRx to expand low-cost drug access - 10 month(s) ago
The CVS Health company’s members will have access to GoodRx’s generic drug prices through the new program, Caremark Cost Saver.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The online pharmacy is partnering with GSK, Kaléo, Novo Nordisk and Dexcom to include coupons for their brand-name medications.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Responding to policy changes and pressure over high drug costs, the drug maker is reducing the sticker price of four branded diabetes medicines by up to 75%.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
Multiple studies have shown no correlation between R&D costs and the launch price of new drugs. But it's an argument used by drugmakers to prevent a cap on pricing. #drugpricing @razormetrics https://t.co/wp2MB6L7nB